Stocks Briefing
Biogen (BIIB) Stock Rose 45% Pre-Market. How Did That Happen?
In pre-hour trades, Biogen Inc. (BIIB) shares gained 45.61% to $288.00 after a surprise trial success. BIIB stock closed at $197.79, up just 1.04%. What
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
